サマリー

市場分析と洞察。世界のウイルスベクター製造サービス市場
世界のViral Vector Manufacturing Services市場規模は、2020年のXX百万米ドルから、2021-2027年の間にXX％のCAGRで、2027年にXX百万米ドルに達すると予測しています。
本レポートは、業界標準の正確な分析と高いデータの整合性により、世界のウイルスベクター製造サービス市場で得られる主要な機会を明らかにし、プレイヤーが市場での確固たる地位を獲得するのに役立つことを目的としています。本レポートの購入者は、収益面での世界のウイルスベクター製造サービス市場の全体的なサイズを含む、検証された信頼できる市場予測にアクセスすることができます。
本レポートは、プレイヤーが競合他社に対して優位に立ち、世界のViral Vector Manufacturing Services市場で永続的な成功を収めるための有効なツールであることを証明しています。本レポートに掲載されている調査結果、データ、情報はすべて、信頼できる情報源の助けを借りて検証、再検証されています。本レポートを執筆したアナリストは、世界のウイルスベクター製造サービス市場を詳細に調査するために、独自の業界最高水準の調査・分析手法を用いています。

世界のウイルスベクター製造サービスの範囲と市場規模
ウイルスベクター製造サービス市場は、企業別、地域（国）別、タイプ別、アプリケーション別に分類されています。世界のViral Vector Manufacturing Services市場に参加するプレイヤー、ステークホルダー、その他の参加者は、このレポートを強力なリソースとして利用することで、優位に立つことができるでしょう。セグメント別分析では、2016年から2027年の期間で、タイプ別とアプリケーション別の収益と予測に焦点を当てています。

タイプ別セグメント
レトロウイルスベクター
アデノウイルスベクター
アデノ随伴ウイルスベクター
その他のウイルスベクター

用途別セグメント
製薬会社、バイオ製薬会社
研究機関

地域別
北アメリカ
アメリカ
カナダ
ヨーロッパ
ドイツ
フランス
U.K.
イタリア
ロシア
北欧
その他のヨーロッパ諸国
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア諸国
ラテンアメリカ
メキシコ
ブラジル
その他のラテンアメリカ
中近東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦
その他の中東・アフリカ地域

会社別
ノバセップ
ロンザファーマ＆バイオテック
ABL, Inc.
タカラバイオ
Sartorius
コブラ・バイオロジクス
フィンベクター
富士フイルム Diosynth Biotechnologies
サノフィ
スパーク・セラピューティクス
uniQure

ページTOPに戻る

目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Vector Manufacturing Services Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Retroviral Vectors
1.2.3 Adenoviral Vectors
1.2.4 Adeno-associated Viral Vectors
1.2.5 Other Viral Vectors
1.3 Market by Application
1.3.1 Global Viral Vector Manufacturing Services Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Pharmaceutical and Biopharmaceutical Companies
1.3.3 Research Institutes
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Viral Vector Manufacturing Services Market Perspective (2016-2027)
2.2 Viral Vector Manufacturing Services Growth Trends by Regions
2.2.1 Viral Vector Manufacturing Services Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Viral Vector Manufacturing Services Historic Market Share by Regions (2016-2021)
2.2.3 Viral Vector Manufacturing Services Forecasted Market Size by Regions (2022-2027)
2.3 Viral Vector Manufacturing Services Industry Dynamic
2.3.1 Viral Vector Manufacturing Services Market Trends
2.3.2 Viral Vector Manufacturing Services Market Drivers
2.3.3 Viral Vector Manufacturing Services Market Challenges
2.3.4 Viral Vector Manufacturing Services Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Viral Vector Manufacturing Services Players by Revenue
3.1.1 Global Top Viral Vector Manufacturing Services Players by Revenue (2016-2021)
3.1.2 Global Viral Vector Manufacturing Services Revenue Market Share by Players (2016-2021)
3.2 Global Viral Vector Manufacturing Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Viral Vector Manufacturing Services Revenue
3.4 Global Viral Vector Manufacturing Services Market Concentration Ratio
3.4.1 Global Viral Vector Manufacturing Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Vector Manufacturing Services Revenue in 2020
3.5 Viral Vector Manufacturing Services Key Players Head office and Area Served
3.6 Key Players Viral Vector Manufacturing Services Product Solution and Service
3.7 Date of Enter into Viral Vector Manufacturing Services Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Viral Vector Manufacturing Services Breakdown Data by Type
4.1 Global Viral Vector Manufacturing Services Historic Market Size by Type (2016-2021)
4.2 Global Viral Vector Manufacturing Services Forecasted Market Size by Type (2022-2027)

5 Viral Vector Manufacturing Services Breakdown Data by Application
5.1 Global Viral Vector Manufacturing Services Historic Market Size by Application (2016-2021)
5.2 Global Viral Vector Manufacturing Services Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Viral Vector Manufacturing Services Market Size (2016-2027)
6.2 North America Viral Vector Manufacturing Services Market Size by Type
6.2.1 North America Viral Vector Manufacturing Services Market Size by Type (2016-2021)
6.2.2 North America Viral Vector Manufacturing Services Market Size by Type (2022-2027)
6.2.3 North America Viral Vector Manufacturing Services Market Size by Type (2016-2027)
6.3 North America Viral Vector Manufacturing Services Market Size by Application
6.3.1 North America Viral Vector Manufacturing Services Market Size by Application (2016-2021)
6.3.2 North America Viral Vector Manufacturing Services Market Size by Application (2022-2027)
6.3.3 North America Viral Vector Manufacturing Services Market Size by Application (2016-2027)
6.4 North America Viral Vector Manufacturing Services Market Size by Country
6.4.1 North America Viral Vector Manufacturing Services Market Size by Country (2016-2021)
6.4.2 North America Viral Vector Manufacturing Services Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Viral Vector Manufacturing Services Market Size (2016-2027)
7.2 Europe Viral Vector Manufacturing Services Market Size by Type
7.2.1 Europe Viral Vector Manufacturing Services Market Size by Type (2016-2021)
7.2.2 Europe Viral Vector Manufacturing Services Market Size by Type (2022-2027)
7.2.3 Europe Viral Vector Manufacturing Services Market Size by Type (2016-2027)
7.3 Europe Viral Vector Manufacturing Services Market Size by Application
7.3.1 Europe Viral Vector Manufacturing Services Market Size by Application (2016-2021)
7.3.2 Europe Viral Vector Manufacturing Services Market Size by Application (2022-2027)
7.3.3 Europe Viral Vector Manufacturing Services Market Size by Application (2016-2027)
7.4 Europe Viral Vector Manufacturing Services Market Size by Country
7.4.1 Europe Viral Vector Manufacturing Services Market Size by Country (2016-2021)
7.4.2 Europe Viral Vector Manufacturing Services Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Viral Vector Manufacturing Services Market Size (2016-2027)
8.2 Asia-Pacific Viral Vector Manufacturing Services Market Size by Type
8.2.1 Asia-Pacific Viral Vector Manufacturing Services Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Viral Vector Manufacturing Services Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Viral Vector Manufacturing Services Market Size by Type (2016-2027)
8.3 Asia-Pacific Viral Vector Manufacturing Services Market Size by Application
8.3.1 Asia-Pacific Viral Vector Manufacturing Services Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Viral Vector Manufacturing Services Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Viral Vector Manufacturing Services Market Size by Application (2016-2027)
8.4 Asia-Pacific Viral Vector Manufacturing Services Market Size by Region
8.4.1 Asia-Pacific Viral Vector Manufacturing Services Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Viral Vector Manufacturing Services Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Viral Vector Manufacturing Services Market Size (2016-2027)
9.2 Latin America Viral Vector Manufacturing Services Market Size by Type
9.2.1 Latin America Viral Vector Manufacturing Services Market Size by Type (2016-2021)
9.2.2 Latin America Viral Vector Manufacturing Services Market Size by Type (2022-2027)
9.2.3 Latin America Viral Vector Manufacturing Services Market Size by Type (2016-2027)
9.3 Latin America Viral Vector Manufacturing Services Market Size by Application
9.3.1 Latin America Viral Vector Manufacturing Services Market Size by Application (2016-2021)
9.3.2 Latin America Viral Vector Manufacturing Services Market Size by Application (2022-2027)
9.3.3 Latin America Viral Vector Manufacturing Services Market Size by Application (2016-2027)
9.4 Latin America Viral Vector Manufacturing Services Market Size by Country
9.4.1 Latin America Viral Vector Manufacturing Services Market Size by Country (2016-2021)
9.4.2 Latin America Viral Vector Manufacturing Services Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Viral Vector Manufacturing Services Market Size (2016-2027)
10.2 Middle East & Africa Viral Vector Manufacturing Services Market Size by Type
10.2.1 Middle East & Africa Viral Vector Manufacturing Services Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Viral Vector Manufacturing Services Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Viral Vector Manufacturing Services Market Size by Type (2016-2027)
10.3 Middle East & Africa Viral Vector Manufacturing Services Market Size by Application
10.3.1 Middle East & Africa Viral Vector Manufacturing Services Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Viral Vector Manufacturing Services Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Viral Vector Manufacturing Services Market Size by Application (2016-2027)
10.4 Middle East & Africa Viral Vector Manufacturing Services Market Size by Country
10.4.1 Middle East & Africa Viral Vector Manufacturing Services Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Viral Vector Manufacturing Services Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Novasep
11.1.1 Novasep Company Details
11.1.2 Novasep Business Overview
11.1.3 Novasep Viral Vector Manufacturing Services Introduction
11.1.4 Novasep Revenue in Viral Vector Manufacturing Services Business (2016-2021)
11.1.5 Novasep Recent Development
11.2 Lonza Pharma & Biotech
11.2.1 Lonza Pharma & Biotech Company Details
11.2.2 Lonza Pharma & Biotech Business Overview
11.2.3 Lonza Pharma & Biotech Viral Vector Manufacturing Services Introduction
11.2.4 Lonza Pharma & Biotech Revenue in Viral Vector Manufacturing Services Business (2016-2021)
11.2.5 Lonza Pharma & Biotech Recent Development
11.3 ABL, Inc.
11.3.1 ABL, Inc. Company Details
11.3.2 ABL, Inc. Business Overview
11.3.3 ABL, Inc. Viral Vector Manufacturing Services Introduction
11.3.4 ABL, Inc. Revenue in Viral Vector Manufacturing Services Business (2016-2021)
11.3.5 ABL, Inc. Recent Development
11.4 Takara Bio
11.4.1 Takara Bio Company Details
11.4.2 Takara Bio Business Overview
11.4.3 Takara Bio Viral Vector Manufacturing Services Introduction
11.4.4 Takara Bio Revenue in Viral Vector Manufacturing Services Business (2016-2021)
11.4.5 Takara Bio Recent Development
11.5 Sartorius
11.5.1 Sartorius Company Details
11.5.2 Sartorius Business Overview
11.5.3 Sartorius Viral Vector Manufacturing Services Introduction
11.5.4 Sartorius Revenue in Viral Vector Manufacturing Services Business (2016-2021)
11.5.5 Sartorius Recent Development
11.6 Cobra Biologics
11.6.1 Cobra Biologics Company Details
11.6.2 Cobra Biologics Business Overview
11.6.3 Cobra Biologics Viral Vector Manufacturing Services Introduction
11.6.4 Cobra Biologics Revenue in Viral Vector Manufacturing Services Business (2016-2021)
11.6.5 Cobra Biologics Recent Development
11.7 Finvector
11.7.1 Finvector Company Details
11.7.2 Finvector Business Overview
11.7.3 Finvector Viral Vector Manufacturing Services Introduction
11.7.4 Finvector Revenue in Viral Vector Manufacturing Services Business (2016-2021)
11.7.5 Finvector Recent Development
11.8 Fujifilm Diosynth Biotechnologies
11.8.1 Fujifilm Diosynth Biotechnologies Company Details
11.8.2 Fujifilm Diosynth Biotechnologies Business Overview
11.8.3 Fujifilm Diosynth Biotechnologies Viral Vector Manufacturing Services Introduction
11.8.4 Fujifilm Diosynth Biotechnologies Revenue in Viral Vector Manufacturing Services Business (2016-2021)
11.8.5 Fujifilm Diosynth Biotechnologies Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Viral Vector Manufacturing Services Introduction
11.9.4 Sanofi Revenue in Viral Vector Manufacturing Services Business (2016-2021)
11.9.5 Sanofi Recent Development
11.10 Spark Therapeutics
11.10.1 Spark Therapeutics Company Details
11.10.2 Spark Therapeutics Business Overview
11.10.3 Spark Therapeutics Viral Vector Manufacturing Services Introduction
11.10.4 Spark Therapeutics Revenue in Viral Vector Manufacturing Services Business (2016-2021)
11.10.5 Spark Therapeutics Recent Development
11.11 uniQure
11.11.1 uniQure Company Details
11.11.2 uniQure Business Overview
11.11.3 uniQure Viral Vector Manufacturing Services Introduction
11.11.4 uniQure Revenue in Viral Vector Manufacturing Services Business (2016-2021)
11.11.5 uniQure Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details